40 Speen Street, Suite 102

Framingham, Massachusetts 01701


September 19, 2019




Securities and Exchange Commission

100 F. Street, N.E.

Washington, D.C. 20549


Re:Xenetic Biosciences, Inc.
 Registration Statement on Form S-3
 File No. 333-233769


Ladies and Gentlemen:


Pursuant to Rule 461 of the General Rules and Regulations promulgated under the Securities Act of 1933, as amended, Xenetic Biosciences, Inc. hereby requests that its Registration Statement on Form S-3 (File No. 333-233769) filed with the Securities and Exchange Commission (the “Commission”) on September 13, 2019 be declared effective by the Commission at 4:00 p.m. Eastern Time on Monday, September 23, 2019, or as soon thereafter as practical.


Once the Registration Statement is declared effective, please orally confirm that event with our counsel, Akerman LLP by calling Michael Francis at (305) 982-5581.


Thank you for your assistance.




/s/ James Parslow


James Parslow

Chief Financial Officer